[1]
“Front-Line Management of Mantle Cell Lymphoma in Canada: A Practical, Risk-Adapted Approach”, Can Hematol Today, vol. 5, no. 2, pp. 26–36, Sep. 2026, doi: 10.58931/cht.2026.5290.